Authors


Jennifer Barrett, Assistant Editor

Latest:

Novel Drug May Help Reduce Tumor Growth, Slow Progression of Liver Cancer

Researchers have developed a novel peptide drug called FFW that could potentially reduce tumor growth and slow progression of liver cancer.


Katelyn Yamartino, PharmD

Latest:

Utilizing Pharmacogenomics Information to Guide AML Treatment

There are specific treatment options patients may qualify for depending on the cytogenetic or molecular abnormality detected.



Wayne Kuznar

Latest:

First-in-Class Immunotoxin Shows Durable Response in Hairy Cell Leukemia

Moxetumomab pasudotox is a nonchemotherapeutic drug that could become the standard of care for patients with relapsed/refractory hairy cell leukemia.


Maryann Dowd, RPh

Latest:

Challenges in Brand Strategies for Tweener Products

The best patient and provider experience will result in a coordination of efforts across the channel continuum.


Amanda DeMarzo, PharmD, MBA, PACS

Latest:

Pharmacy Residency Is Not the End-All-Be-All for Pharmacy Students

Although a residency is beneficial for traditional career paths, a career can be more than working inside a pharmacy.


Janet Kingsley-Chiong, PharmD, BCGP, RPh, MTM Certified

Latest:

Weave Pharmacogenomics Drug-Gene Interactions Into MTM

Keep a critical eye on whether precautions should be taken or a change in therapy is warranted.


Ahmed Ragab, BS

Latest:

Increases in Utilization Management of Oncology Medicines by US Payers

Recent increases in the number of therapies indicated for a given oncology subtype has resulted in heightened utilization management stringency.



Rupal Mansukhani, PharmD, FAPhA, CTTS

Latest:

Postnasal Drip

Experts answer questions to help provide relief for those suffering with postnasal drip.


Chris Coburn

Latest:

How Government Pricing Professionals Became Pharmaceutical Industry Change Agents

The world of government pricing (GP), once a mystery to many in the pharmacy industry, is considered to be a key component of strategic and compliance activity. For pharmaceutical manufacturers, government business is a top priority.


Jessica Chasler, PharmD

Latest:

Prescribing Patterns of Novel Anticoagulants Within a Statewide Multispecialty Practice

While warfarin remains the most commonly prescribed anticoagulant, novel anticoagulant use appears to be increasing especially among cardiologists. With new indications for these agents, uptake in prescribing by primary care providers is likely to increase.



LeAnn B Norris, PharmD, FCCP, BCPS, BCOP

Latest:

Progress in Treating Advanced Melanoma: Pharmacists' Roles in Improving Outcomes

Progress in Treating Advanced Melanoma: Pharmacists’ Roles in Improving Outcomes



Hannah Renner, PharmD

Latest:

Adult Immunizations: Are Your Patients Up-to-Date?

In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.


Dan Steiber, RPh, Specialty Pharmacy Times® Editor-In-Chief & Executive Vice President

Latest:

Community “Specialty” Pharmacy vs the Competition

Given the state of political affairs currently engulfing health care, our industry regularly gets vilified and is frequently a victim of misperception.


Ashley N. Lewis PharmD, BCPS

Latest:

Neostigmine Methylsulfate Injection (Bloxiverz)

Bloxiverz, manufactured by Éclat Pharmaceuticals, is the first and only FDA-approved neostigmine methylsulfate injection.


Sean T. Lasota, PharmD

Latest:

Implementation Strategy to Bring Medication Therapy Management Into High-­Volume Community Pharmacies

This study shows how medication therapy management can be integrated into challenging pharmacy work flow, and also assesses the resulting benefits, both clinical and financial.



Neeta Tandon, MA

Latest:

Direct and Indirect Cost Burden of Chronic Hepatitis C

An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.


Margaret A. Farley, MBA

Latest:

Patient Adherence: Identifying Barriers and Defining Solutions

Major patient and professional advocacy organizations discussed factors leading to patient nonadherence to prescription therapy and solutions for overcoming the major barriers.


Lisa Davila, MS, RN

Latest:

An Absence of Essential Skills in the Current Healthcare Landscape

Whether managing other healthcare workers or working on the frontline with patients every day, professionals can help foster a culture where learning soft skills is a priority.


David B. Wortman

Latest:

Why the Consumerization of Health Care Lies in Better Communication

It comes as no surprise that as health care organizations look for ways to improve outreach to their patients, they look first to HIPAA"compliant texting services.


John Colaizzi, PhD, RPh

Latest:

Are Pharmacy Schools Growing Too Fast?

Pharmacy schools have been growing at an unprecedented rate, and if the trend continues as expected it could pose problems for the future success of the profession.


Randi Hernandez, MS, Associate Editor/Online

Latest:

Incentives for Filing a Product Through the 351(k) Pathway

Steven Lucio of Novation discusses how Teva's Granix (tbo-filgrastim), which was filed through a 351(a) pathway, was approved for only 1 indication--and it was not the indication considered to be the "most definitive" for that particular product.


Veronique Michaud, PhD, BPharm

Latest:

Improve Pain Management With Precision Pharmacotherapy

Leveraging pharmacogenomic testing, simultaneous multidrug analysis can help prevent drug interactions affecting pain management.


Miriam A. Mobley Smith, PharmD, FASHP

Latest:

Adoption of a Uniform Standard for Pharmacy Technician Education: A Professionally Symbiotic or Heretical Concept?

Significant changes in the delivery of health care services within the United States have given pharmacists and pharmacy technicians opportunities to advance in their roles and responsibilities.


Derek M. McMichael, PharmD

Latest:

Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)

The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.


Sean M. Jeffery, PharmD, CGP, FASCP, FNAP

Latest:

Walgreens Severs Ties with ACOs

In a year marked by major changes for the company, Walgreens ends 2 of Its 3 ACO contracts.